Silent Cerebral Infarct Transfusion (SIT) trial imaging core: application of novel imaging information technology for rapid and central review of MRI of the brain.

The Silent Cerebral Infarct Multicenter Transfusion (SIT) Trial is a multi-institutional intervention trial in which children with silent cerebral infarcts are randomized to receive either blood transfusion therapy or observation (standard care) for 36 months. The SIT Trial is scheduled to enroll ap...

Descripción completa

Detalles Bibliográficos
Publicado en:Journal of Digital Imaging Vol. 22; no. 3; pp. 326 - 344
Autores principales: Vendt BA, McKinstry RC, Ball WS, Kraut MA, Prior FW, Barton B, Casella JF, DeBaun MR
Formato: clinical trial pictorial research tables/charts Journal Article
Publicado: Springer Nature Jun2009
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=105525683&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 105525683
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        08971889
        DOQ
      jtl: Journal of Digital Imaging
      issn: 08971889
      maglogo: N
    pubinfo:
      dt: Jun2009
      vid: 22
      iid: 3
      pid: 237
      pub: Springer Nature
      place: New York, New York
    artinfo:
      ui:
        105525683
        2010276426
        10.1007/s10278-008-9114-3
        NLM18398653
        105525683
      ppf: 326
      ppct: 18
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Silent Cerebral Infarct Transfusion (SIT) trial imaging core: application of novel imaging information technology for rapid and central review of MRI of the brain.
      aug:
        au:
          Vendt BA
          McKinstry RC
          Ball WS
          Kraut MA
          Prior FW
          Barton B
          Casella JF
          DeBaun MR
        affil: Electronic Radiology Laboratory, Mallinckrodt Institute of Radiology, Washington University School of Medicine, 510 S. Kingshighway, St. Louis, MO 63110, USA. vendtb@mir.wustl.edu
      sug:
        subj:
          Anemia, Sickle Cell Complications
          Infarction Diagnosis
          Magnetic Resonance Imaging
          Brain Pathology
          Clinical Trials
          Data Management
          Organizational Efficiency
          Reports
          Teleradiology
          Time Factors
          Human
      ab: The Silent Cerebral Infarct Multicenter Transfusion (SIT) Trial is a multi-institutional intervention trial in which children with silent cerebral infarcts are randomized to receive either blood transfusion therapy or observation (standard care) for 36 months. The SIT Trial is scheduled to enroll approximately 1,880 children with sickle cell disease from 29 clinical sites in the United States, Canada, UK, and France. Each child undergoes a screening magnetic resonance imaging (MRI) of the brain to detect the presence of silent cerebral infarct-like lesions, a pre-randomization (baseline) MRI and exit MRI to determine if there are new or enlarged cerebral infarcts, using a designated, prospective imaging protocol. The objective of this manuscript is to describe the innovative method used to process and adjudicate imaging studies for an international trial with a primary endpoint that includes neuroimaging. Institution investigators at each site were provided with computer hardware and software for transmission of MRI images that allow them to strip the scans of all personal information and add unique study identifiers. Three neuroradiologists at separate academic centers review MRI studies and determine the presence or absence of silent cerebral infarct-like lesions. Their findings are subsequently placed on web-based case report forms and sent to the Statistical Coordinating Center. The average time from imaging center receipt of the MRI study to the radiology committee report back to the local site is less than two working days. This novel strategy was designed to maximize efficiency and minimize cost of a complex large multicenter trial that depends heavily on neuroimaging for entry criteria and assessment for the primary outcome measures. The technology, process, and expertise used in the SIT Trial can be adapted to virtually any clinical research trial with digital imaging requirements.
      pubtype: Academic Journal
      doctype:
        clinical trial
        pictorial
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N